controlled clinical trials have demonstrated the value of laser photocoagulation and photodynamic therapy with verteporfin in selected patients with neovascular age-related macular degeneration.

Neovascular age-related macular degeneration is responsible for the overwhelming majority of vision loss in age-related macular degeneration. Not too long ago, the disease was poorly controlled ...

The following is a summary of “Submacular hemorrhage rates following anti-vascular endothelial growth factor injections for ...

An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration (AMD) ...

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

Macular degeneration, also known as age-related macular degeneration (AMD), is the most ... A more severe form of macular degeneration, neovascular or wet AMD, sets on much more rapidly and can lead ...

Wet age-related macular degeneration, or AMD, is a chronic eye condition that damages the macula, a small area near the center of your retina. This part of your eye helps you see objects that are ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

Macular degeneration is the most common cause of age-related vision loss in older adults. In a healthy eye, light travels through the pupil and hits the retina, the inner back layer of your eye.